Khan-Dawood FS

No ORCID on file · 5 papers in corpus
article 1997
American Journal of Obstetrics and Gynecology ·doi:10.1016/s0002-9378(97)70504-0

ObjectiveOur purpose was to determine and compare the efficacy and hormonal and metabolic effects of 1.25 mg with 2.5 mg of gestrinone given twice a week in the treatment of mild and moderate pelvic endometriosis.Study designA phase II, pro…

rct 1995
Fertility and Sterility ·doi:10.1016/s0015-0282(16)57593-1

OBJECTIVE: To determine changes in trabecular vertebral bone mass, serum E2, and serum calcitonin during and after therapy of pelvic endometriosis with depot leuprolide acetate (LA) or danazol. DESIGN: Prospective, randomized, double-blind…

article 1988
American Journal of Obstetrics and Gynecology ·doi:10.1016/0002-9378(88)90588-1

Determined by a sandwich, solid-phase radioimmunoassay with mouse monoclonal antibody, OC 125, plasma CA 125 levels were significantly elevated in stage III (mean +/- SEM = 32.7 +/- 5.2 U/ml, n = 17, p = less than 0.01) and stage IV endomet…

article 1987
Fertility and Sterility ·doi:10.1016/s0015-0282(16)49994-2

This study was undertaken to determine whether women with endometriosis have altered protein, progesterone (P), and protease inhibitor concentrations in their uterine fluid and peritoneal fluid (PF) compared with controls at different phase…

article 1984
American Journal of Obstetrics and Gynecology ·doi:10.1016/0002-9378(84)90713-0

Peritoneal fluid obtained at laparoscopy from 49 women was measured for its content of prostaglandin E2 (PGE2), prostaglandin F2 alpha (PGF2 alpha), 6-keto-prostaglandin F1 alpha (6-KF), and thromboxane B2 (TxB2) by specific radioimmunoassa…